SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-054755
Filing Date
2024-06-21
Accepted
2024-06-21 16:01:12
Documents
13
Period of Report
2023-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0208269-8ka1_aditxt.htm   iXBRL 8-K/A 47848
  Complete submission text file 0001213900-24-054755.txt   233331

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adtx-20231222.xsd EX-101.SCH 3009
3 XBRL LABEL FILE adtx-20231222_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE adtx-20231222_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0208269-8ka1_aditxt_htm.xml XML 4669
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39336 | Film No.: 241060066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)